Acceptability of a trial of vaginal progesterone for the prevention of preterm birth among HIV-infected women in Lusaka, Zambia: A mixed methods study

Antenatal progesterone prevents preterm birth (PTB) in women with a short cervix or prior PTB in daily vaginal or weekly injectable formulations, respectively. Neither has been tested for the indication of maternal HIV, which is associated with an elevated risk of PTB. The Vaginal Progesterone (VP)...

Descripción completa

Detalles Bibliográficos
Autores principales: Price, Joan T., Mabula-Bwalya, Chileshe M., Freeman, Bethany L., Carda-Auten, Jessica, Phiri, Winifreda M., Chibwe, Kasapo, Kantumoya, Patricia, Vwalika, Bellington, Stringer, Jeffrey S. A., Golin, Carol E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7514015/
https://www.ncbi.nlm.nih.gov/pubmed/32970697
http://dx.doi.org/10.1371/journal.pone.0238748

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7514015/
https://www.ncbi.nlm.nih.gov/pubmed/32970697
http://dx.doi.org/10.1371/journal.pone.0238748

Ejemplares similares